GlassScriptPhysician profile
Dilip Tapadiya
NPI 1275607350
$1,167.22
in general payments reported to CMS, 2019-2025
7 companies · $36.15 in 2025
The $36.15 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,063 · 2022: $68.03 · 2025: $36.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $36.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $36.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corin USA | $711.69 | 2019 | |
| Zimmer Biomet Holdings, INC. | $335.23 | 2019 | |
| Organogenesis INC. | $36.15 | 2025 | Affinity |
| Ethicon US, LLC | $32.35 | 2022 | |
| Integra Lifesciences Corporation | $21.00 | 2022 | |
| Stryker Corporation | $16.12 | 2019 | |
| Smith+Nephew, INC. | $14.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dilip Tapadiya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.